Evidence map›Paper›PMID 41096910›Full record

ArticleInternational journal of molecular sciences2025

T-Cadherin Finetunes Proliferation-Differentiation During Adipogenesis via PI3K-AKT Signaling Pathway.

Polina Klimovich, Ilya Brodsky, Valentina Dzreyan, Marianna Ivleva, Olga Grigorieva, Mark Meshcheriakov, Ekaterina Semina, Veronika Sysoeva, Vsevolod Tkachuk, Kseniya Rubina

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Polina KlimovichFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-8260-5542
Ilya BrodskyFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Valentina DzreyanFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0003-3249-5020
Marianna IvlevaFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0009-0004-0058-3709
Olga GrigorievaCenter for Regenerative Medicine, Medical Research and Education Institute, Lomonosov Moscow State University, 119192 Moscow, Russia.
Mark MeshcheriakovFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Ekaterina SeminaFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-3927-9286
Veronika SysoevaFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0001-9885-9056
Vsevolod TkachukFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Kseniya RubinaFaculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-7166-7406

Funding

Lomonosov Moskow State University 03р-23/110-03Russian Science Foundation 23-11-00205
6 · The paper itself

Abstract

Adipose tissue renewal requires precise coordination of stem/progenitor cell proliferation, preadipocyte commitment, and terminal adipocyte differentiation. T-cadherin (CDH13), an atypical GPI-anchored cadherin, is expressed in adipose tissue and functions as a receptor for high-molecular-weight (HMW) adiponectin-a key adipokine produced by adipose tissue and involved in metabolic regulation. While T-cadherin is implicated in cardiovascular and metabolic homeostasis, its role in adipogenesis still remains poorly understood. In this study, we used the 3T3-L1 preadipocyte model to investigate the function of T-cadherin in adipocyte differentiation. We analyzed T-cadherin expression dynamics during differentiation and assessed how T-cadherin overexpression or knockdown affects lipid accumulation, expression of adipogenic markers, and key signaling pathways including ERK, PI3K-AKT, AMPK, and mTOR. Our findings demonstrate that T-cadherin acts as a negative regulator of adipogenesis. T-cadherin overexpression ensured a proliferative, undifferentiated cell state, delaying early adipogenic differentiation and suppressing both lipid droplet accumulation and the expression of adipogenic markers. In contrast, T-cadherin downregulation accelerated differentiation, enhanced lipid accumulation, and increased insulin responsiveness, as indicated by PI3K-AKT pathway activation at specific stages of adipogenesis. These results position T-cadherin as a key modulator of adipose tissue plasticity, regulating the balance between progenitor expansion and terminal differentiation, with potential relevance to obesity and metabolic disease.

Indexed as

AdipogenesisCadherinsCell DifferentiationPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal Transduction3T3-L1 CellsAdipocytesAnimalsCell ProliferationMiceCadherinsH-cadherinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt3T3-L1adipogenesisadiponectinCDH13insulin signalingT-cadherin

Identifiers

PMID41096910
PMCPMC12524427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.